$QLYS
Qualys Inc

2023 Q2 Form 10-Q Financial Statement

#000143774923012595 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $137.2M $130.7M $113.4M
YoY Change 14.44% 15.22% 17.22%
Cost Of Revenue $26.66M $26.95M $24.00M
YoY Change 6.45% 12.3% 10.71%
Gross Profit $110.5M $103.7M $89.42M
YoY Change 16.55% 16.0% 19.1%
Gross Profit Margin 80.57% 79.37% 78.84%
Selling, General & Admin $40.30M $40.76M $32.78M
YoY Change 8.72% 24.35% -45.4%
% of Gross Profit 36.45% 39.29% 36.65%
Research & Development $27.42M $27.80M $23.11M
YoY Change 10.62% 20.29% 30.19%
% of Gross Profit 24.81% 26.8% 25.84%
Depreciation & Amortization $7.002M $7.444M $8.982M
YoY Change -18.3% -17.12% -1.06%
% of Gross Profit 6.33% 7.18% 10.04%
Operating Expenses $67.72M $68.55M $55.88M
YoY Change 9.48% 22.67% -28.15%
Operating Profit $42.83M $35.18M $33.54M
YoY Change 29.81% 4.9% -1339.74%
Interest Expense $3.394M $2.231M $0.00
YoY Change -100.0%
% of Operating Profit 7.92% 6.34% 0.0%
Other Income/Expense, Net -$544.0K $2.181M -$192.0K
YoY Change -37.54% -1235.94% -138.55%
Pretax Income $45.68M $37.36M $33.34M
YoY Change 42.2% 12.04% -1610.78%
Income Tax $10.30M $8.300M $7.900M
% Of Pretax Income 22.54% 22.22% 23.69%
Net Earnings $35.38M $29.11M $25.41M
YoY Change 33.04% 14.54% 11044.74%
Net Earnings / Revenue 25.79% 22.27% 22.4%
Basic Earnings Per Share $0.96 $0.79 $0.65
Diluted Earnings Per Share $0.95 $0.77 $0.64
COMMON SHARES
Basic Shares Outstanding 36.90M 37.01M 38.99M
Diluted Shares Outstanding 37.44M 37.67M 40.00M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $349.3M $333.8M $457.1M
YoY Change -16.66% -26.99% 28.14%
Cash & Equivalents $186.1M $193.9M $166.3M
Short-Term Investments $163.1M $139.9M $290.9M
Other Short-Term Assets $34.02M $29.18M $26.75M
YoY Change -2.69% 9.09% 21.05%
Inventory
Prepaid Expenses
Receivables $124.9M $101.8M $89.29M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $508.2M $464.7M $573.2M
YoY Change -7.89% -18.92% 23.52%
LONG-TERM ASSETS
Property, Plant & Equipment $68.34M $45.16M $63.38M
YoY Change 18.18% -28.74% -1.19%
Goodwill $7.447M $7.447M $7.447M
YoY Change 0.0% 0.0% 0.0%
Intangibles $11.26M $12.03M $4.839M
YoY Change 234.56% 148.61% -53.3%
Long-Term Investments $38.84M $44.59M $82.36M
YoY Change -51.53% -45.86% -18.86%
Other Assets $75.52M $18.48M $17.59M
YoY Change 309.76% 5.06% -4.22%
Total Long-Term Assets $201.4M $211.0M $241.4M
YoY Change -15.12% -12.58% -9.22%
TOTAL ASSETS
Total Short-Term Assets $508.2M $464.7M $573.2M
Total Long-Term Assets $201.4M $211.0M $241.4M
Total Assets $709.6M $675.8M $814.6M
YoY Change -10.07% -17.04% 11.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.160M $1.740M $2.477M
YoY Change 1.31% -29.75% 112.8%
Accrued Expenses $64.51M $41.78M $37.08M
YoY Change 69.83% 12.66% 33.22%
Deferred Revenue $302.4M $296.5M $266.9M
YoY Change 9.69% 11.08% 21.94%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $369.1M $353.0M $318.5M
YoY Change 12.75% 10.81% 22.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $63.45M $7.129M $4.976M
YoY Change 1146.24% 43.27% 258.5%
Total Long-Term Liabilities $63.45M $7.129M $4.976M
YoY Change 1146.24% 43.27% 258.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $369.1M $353.0M $318.5M
Total Long-Term Liabilities $63.45M $7.129M $4.976M
Total Liabilities $432.6M $407.9M $387.9M
YoY Change 10.3% 5.16% 16.55%
SHAREHOLDERS EQUITY
Retained Earnings -$255.3M -$252.4M -$58.41M
YoY Change 165.12% 332.05% 143.36%
Common Stock $37.00K $37.00K $39.00K
YoY Change -5.13% -5.13% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $277.0M $267.8M $426.6M
YoY Change
Total Liabilities & Shareholders Equity $709.6M $675.8M $814.6M
YoY Change -10.07% -17.04% 11.59%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $35.38M $29.11M $25.41M
YoY Change 33.04% 14.54% 11044.74%
Depreciation, Depletion And Amortization $7.002M $7.444M $8.982M
YoY Change -18.3% -17.12% -1.06%
Cash From Operating Activities $51.52M $66.81M $79.04M
YoY Change 52.36% -15.47% 36.62%
INVESTING ACTIVITIES
Capital Expenditures $1.418M $4.037M $7.639M
YoY Change -140.39% -47.15% 22.05%
Acquisitions
YoY Change
Other Investing Activities -$15.97M $23.70M $3.115M
YoY Change 150.96% 660.8% -89.4%
Cash From Investing Activities -$17.39M $19.66M -$4.524M
YoY Change 76.09% -534.62% -119.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.58M
YoY Change 50.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -41.83M -$66.34M -$45.56M
YoY Change -39.6% 45.62% -1.83%
NET CHANGE
Cash From Operating Activities 51.52M $66.81M $79.04M
Cash From Investing Activities -17.39M $19.66M -$4.524M
Cash From Financing Activities -41.83M -$66.34M -$45.56M
Net Change In Cash -7.709M $20.14M $28.96M
YoY Change -82.99% -30.47% -16.35%
FREE CASH FLOW
Cash From Operating Activities $51.52M $66.81M $79.04M
Capital Expenditures $1.418M $4.037M $7.639M
Free Cash Flow $50.10M $62.78M $71.40M
YoY Change 34.23% -12.08% 38.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7129000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7013000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
407931000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
411812000 usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
912000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
736000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36933000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36933000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37362000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37362000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35662
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0534145
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
919 E. Hillsdale Boulevard, 4th Floor,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Foster City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94404
CY2023Q1 dei City Area Code
CityAreaCode
650
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
801-6100
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
QLYS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36895797
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193854000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173719000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
139925000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
147608000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101786000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
121795000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29183000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30216000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
464748000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
473338000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
44587000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
59206000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45161000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47428000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30737000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33752000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
49865000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
45412000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12030000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12801000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
7447000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
7447000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2700000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2700000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18478000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18857000 usd
CY2023Q1 us-gaap Assets
Assets
675753000 usd
CY2022Q4 us-gaap Assets
Assets
700941000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1740000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2808000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41777000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42592000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
296516000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
293728000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12925000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13060000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
352958000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
352188000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
21931000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23490000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25913000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29121000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
521716000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
512486000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1571000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1947000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252360000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-221447000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
267822000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
289129000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
675753000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
700941000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130683000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113420000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
26954000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
24002000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
103729000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
89418000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27795000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23107000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25628000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20142000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15128000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12634000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
68551000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
55883000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35178000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33535000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2397000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
518000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-216000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-710000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2181000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-192000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37359000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33343000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8254000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7933000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29105000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
25410000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37068000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38992000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37669000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40001000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29105000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
25410000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1131000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2128000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-755000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
451000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
376000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1677000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29481000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23733000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29105000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
25410000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7444000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8982000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
119000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
141000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16033000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11745000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
259000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-762000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4241000 usd
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5095000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19890000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19563000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1289000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6067000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1215000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
599000 usd
CY2023Q1 qlys Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-2000 usd
CY2022Q1 qlys Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
3435000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1228000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7426000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66813000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
79040000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46010000 usd
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
81800000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
69709000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
84915000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4037000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7639000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19662000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4524000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
66551000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46581000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2328000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2569000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5105000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3631000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2988000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2086000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66340000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45557000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20135000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28959000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
176419000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
138528000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
196554000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
167487000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
289129000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29105000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
376000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2328000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
67032000 usd
CY2023Q1 qlys Stock Issued During Period Value Restricted Stock Award Vested
StockIssuedDuringPeriodValueRestrictedStockAwardVested
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5105000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2988000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16033000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
267822000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
436714000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
25410000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1677000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2569000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
46581000 usd
CY2022Q1 qlys Stock Issued During Period Value Restricted Stock Award Vested
StockIssuedDuringPeriodValueRestrictedStockAwardVested
0 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3631000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2086000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11745000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
426635000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:13.5pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:22.5pt;">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date of the condensed consolidated financial statements and the reported results of operations during the reporting period. The Company’s management regularly assesses these estimates, which primarily affect revenue recognition, allowance for credit loss, the valuation of goodwill and intangible assets, leases, stock-based compensation and income tax provision. Actual results could differ from those estimates and such differences <em style="font: inherit;"> may </em>be material to the accompanying unaudited condensed consolidated financial statements.</p>
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33839000 usd
CY2023Q1 qlys Cash Equivalents Unrealized Gains
CashEquivalentsUnrealizedGains
0 usd
CY2023Q1 qlys Cash Equivalents Unrealized Loss
CashEquivalentsUnrealizedLoss
5000 usd
CY2023Q1 qlys Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
33834000 usd
CY2023Q1 qlys Available For Sale Debt Securities Amortized Cost Basis Current
AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
140636000 usd
CY2023Q1 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
8000 usd
CY2023Q1 qlys Availableforsale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current
AvailableforsaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
719000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
139925000 usd
CY2023Q1 qlys Available For Sale Debt Securities Amortized Cost Basis Noncurrent
AvailableForSaleDebtSecuritiesAmortizedCostBasisNoncurrent
45446000 usd
CY2023Q1 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
0 usd
CY2023Q1 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
859000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
44587000 usd
CY2023Q1 qlys Cash And Cash Equivalent And Debt Securities Availableforsale Amortized Cost Total
CashAndCashEquivalentAndDebtSecuritiesAvailableforsaleAmortizedCostTotal
219921000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1583000 usd
CY2023Q1 qlys Cash And Cash Equivalent And St And Lt Debt Securities Availableforsale Fair Value Disclosure
CashAndCashEquivalentAndStAndLtDebtSecuritiesAvailableforsaleFairValueDisclosure
218346000 usd
CY2023Q1 us-gaap Cash
Cash
160000000.0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
112488000 usd
CY2022Q4 qlys Cash Equivalents Unrealized Gains
CashEquivalentsUnrealizedGains
4000 usd
CY2022Q4 qlys Cash Equivalents Unrealized Loss
CashEquivalentsUnrealizedLoss
0 usd
CY2022Q4 qlys Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
112492000 usd
CY2022Q4 qlys Available For Sale Debt Securities Amortized Cost Basis Current
AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
148867000 usd
CY2022Q4 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
3000 usd
CY2022Q4 qlys Availableforsale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current
AvailableforsaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
1262000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
147608000 usd
CY2022Q4 qlys Available For Sale Debt Securities Amortized Cost Basis Noncurrent
AvailableForSaleDebtSecuritiesAmortizedCostBasisNoncurrent
60657000 usd
CY2022Q4 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
0 usd
CY2022Q4 qlys Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
1451000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
59206000 usd
CY2022Q4 qlys Cash And Cash Equivalent And Debt Securities Availableforsale Amortized Cost Total
CashAndCashEquivalentAndDebtSecuritiesAvailableforsaleAmortizedCostTotal
322012000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2713000 usd
CY2022Q4 qlys Cash And Cash Equivalent And St And Lt Debt Securities Availableforsale Fair Value Disclosure
CashAndCashEquivalentAndStAndLtDebtSecuritiesAvailableforsaleFairValueDisclosure
319306000 usd
CY2022Q4 us-gaap Cash
Cash
61200000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
148612000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
671000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
47344000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
912000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
195956000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1583000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
137965000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1690000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
64811000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1023000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
202776000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2713000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
174452000 usd
CY2023Q1 qlys Availableforsale Securities Debt Maturities Next Twelve Months Fair Value
AvailableforsaleSecuritiesDebtMaturitiesNextTwelveMonthsFairValue
173736000 usd
CY2023Q1 qlys Debt Securities Availableforsale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesAvailableforsaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
36846000 usd
CY2023Q1 qlys Availableforsale Securities Debt Maturities Year One Through Two Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughTwoFairValue
36064000 usd
CY2023Q1 qlys Debt Securities Availableforsale Amortized Cost Maturity Allocated And Single Maturity Date After Year Two
DebtSecuritiesAvailableforsaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwo
0 usd
CY2023Q1 qlys Availableforsale Securities Debt Maturities After Year Two Fair Value
AvailableforsaleSecuritiesDebtMaturitiesAfterYearTwoFairValue
0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
219921000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
218346000 usd
CY2023Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
199000 usd
CY2022Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
1493000 usd
CY2023Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
3121000 usd
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
4679000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47428000 usd
CY2023Q1 qlys Depreciation Depletion And Amortization Excluding Intangible Asset Amortization
DepreciationDepletionAndAmortizationExcludingIntangibleAssetAmortization
6500000 usd
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
259000 usd
CY2022Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1155000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-425000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1818000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-166000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-663000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
50000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
47000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-216000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-710000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
247105000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
242869000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
201944000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
195441000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45161000 usd
CY2022Q1 qlys Depreciation Depletion And Amortization Excluding Intangible Asset Amortization
DepreciationDepletionAndAmortizationExcludingIntangibleAssetAmortization
7100000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
113800000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000000.0 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
317200000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
290600000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
131257000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
106502000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
47649000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5779000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
776000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
69000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
292032000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130683000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113420000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
5120000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
5018000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
10143000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
10090000 usd
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1400000 usd
CY2022Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1200000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42387000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30398000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11990000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12030000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42387000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29626000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12761000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12801000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2314000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2904000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2557000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2477000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1738000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11990000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
4000000.0 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3600000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3905000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4035000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
638000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052 pure
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16033000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11745000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1807000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
87.59
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
58024000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
121000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
121.02
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
38.31
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
29000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
123.18
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1838000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
90.85
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74979000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1614000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
85.86
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
73425000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
996000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
62.04
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
67948000 usd
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000.0 usd
CY2018Q4 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
100000000.0 usd
CY2019Q4 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
100000000.0 usd
CY2020Q2 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
100000000.0 usd
CY2021Q1 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
100000000.0 usd
CY2021Q4 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
200000000.0 usd
CY2022Q2 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
200000000.0 usd
CY2023Q1 qlys Stock Repurchase Program Additional Authorized Amount1
StockRepurchaseProgramAdditionalAuthorizedAmount1
100000000.0 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
584000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
368000
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
66600000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
46600000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
187900000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29105000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
25410000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37068000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38992000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
489000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
770000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
110000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
236000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
2000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
3000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37669000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40001000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1369000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
609000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8300000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238 pure
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10700000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5400000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10500000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5300000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130683000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113420000 usd
CY2023Q1 qlys Property Plant And Equipment And Operating Lease Rightofuse Assets
PropertyPlantAndEquipmentAndOperatingLeaseRightofuseAssets
75898000 usd
CY2022Q4 qlys Property Plant And Equipment And Operating Lease Rightofuse Assets
PropertyPlantAndEquipmentAndOperatingLeaseRightofuseAssets
81180000 usd

Files In Submission

Name View Source Status
0001437749-23-012595-index-headers.html Edgar Link pending
0001437749-23-012595-index.html Edgar Link pending
0001437749-23-012595.txt Edgar Link pending
0001437749-23-012595-xbrl.zip Edgar Link pending
ex_468849.htm Edgar Link pending
ex_468850.htm Edgar Link pending
ex_468851.htm Edgar Link pending
ex_468852.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qlys-20230331.xsd Edgar Link pending
qlys20230331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
qlys-20230331_def.xml Edgar Link unprocessable
qlys-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
qlys-20230331_pre.xml Edgar Link unprocessable
qlys-20230331_lab.xml Edgar Link unprocessable
qlys20230331_10q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending